ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

The t(8;21) translocation between two genes known as AML1 and ETO is seen in approximately 12–15% of all acute myeloid leukemia (AML) and is the second-most-frequently observed nonrandom genetic alteration associated with AML. AML1 up-regulates a number of target genes critical to normal hematopoies...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Proc Natl Acad Sci U S A
Autori principali:	Wang, Jianxiang, Hoshino, Taizo, Redner, Robert L., Kajigaya, Sachiko, Liu, Johnson M.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	National Academy of Sciences 1998
Soggetti:	Biological Sciences
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27986/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9724795/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.18.10860
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!